John E. Knox

2.1k citations

29 papers · 806 · h-index 16

Impact in

Virology top 10%
- HIV Research and Treatment
Public Health, Environmental and Occupational Health top 5%
- Mosquito-borne diseases and control
- Malaria Research and Control

Papers in

Molecular Biology 12
- Ubiquitin and proteasome pathways 6
- 14-3-3 protein interactions 4
- Signaling Pathways in Disease 3
Organic Chemistry 8
- Organometallic Complex Synthesis and Catalysis 4

Co-authors: H. Bernhard Schlegel (11 shared papers)Thomas H. Keller (6 shared papers)Mary Jane Heeg (8 shared papers)Charles H. Winter (8 shared papers)Zheng Yin (4 shared papers)Subhash G. Vasudevan (4 shared papers)Siew Pheng Lim (4 shared papers)Ngai Ling (4 shared papers)
Journals: Cancer Research (6 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Inorganic Chemistry (2 papers)European Journal of Inorganic Chemistry (2 papers)Journal of Antimicrobial Chemotherapy (1 paper)
Partner nations: United States Singapore Switzerland

In The Last Decade

John E. Knox

28 papers receiving 776 citations

Peers

Countries citing papers authored by John E. Knox

Since Specialization

Citations

This map shows the geographic impact of John E. Knox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Knox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Knox more than expected).

Fields of papers citing papers by John E. Knox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Knox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Knox. The network helps show where John E. Knox may publish in the future.

Co-authors

The 25 scholars most cited alongside John E. Knox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John E. Knox Line = papers co-authored together John E. Knox links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors Bioorganic & Medicinal Chemistry Letters ·Zheng Yin, Sejal Patel, Weiling Wang, Wai-Ling Chan, K. R. Ranga Rao, Gang Wang, Xinyi Ngew, Viral Patel, David Beer, John E. Knox, Ngai Ling, Claus Ehrhardt, Siew Pheng Lim, Subhash G. Vasudevan, Thomas H. Keller	2005	134
2	Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis Journal of Antimicrobial Chemotherapy ·Mekonnen Kurabachew, Shuihua Lu, Philipp Krastel, E. Schmitt, B. L. Suresh, Ai Ting Goh, John E. Knox, N. L., Jan Jiřiček, David Beer, Michael H. Cynamon, Frank Petersen, Véronique Dartois, Thomas H. Keller, Thomas Dick, Vasan K. Sambandamurthy	2008	84
3	Peptide Inhibitors of West Nile NS3 Protease: SAR Study of Tetrapeptide Aldehyde Inhibitors Journal of Medicinal Chemistry ·John E. Knox, Ngai Ling, Zheng Yin, Sejal Patel, Weiling Wang, Wai-Ling Chan, K. R. Ranga Rao, Gang Wang, Xinyi Ngew, Viral Patel, David Beer, Siew Pheng Lim, Subhash G. Vasudevan, Thomas H. Keller	2006	77
4	Chemical failure modes of AlQ3-based OLEDs: AlQ3 hydrolysis Physical Chemistry Chemical Physics ·John E. Knox, Mathew D. Halls, Hrant P. Hratchian, H. Bernhard Schlegel	2006	67
5	Synthesis and antitubercular activity of 7-(R)- and 7-(S)-methyl-2-nitro-6-(S)-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazines, analogues of PA-824 Bioorganic & Medicinal Chemistry Letters ·Xiaojin Li, Ujjini H. Manjunatha, Michael Goodwin, John E. Knox, Christopher A. Lipinski, Thomas H. Keller, Clifton E. Barry, Cynthia S. Dowd	2008	60
6	Finding New Medicines for Flaviviral Targets Novartis Foundation symposium ·Thomas H. Keller, Yen‐Liang Chen, John E. Knox, Siew Pheng Lim, Ngai Ling, Sejal Patel, Aruna Sampath, Qing Yin Wang, Zheng Yin, Subhash G. Vasudevan	2006	43
7	Synthesis, Structure, and Molecular Orbital Calculations of Chromium(III) and Iron(III) Complexes Containingη²-Pyrazolato Ligands Angewandte Chemie International Edition ·K.R. Gust, John E. Knox, Mary Jane Heeg, H. Bernhard Schlegel, Charles H. Winter	2002	32
8	Yellow fever virus NS3 protease: peptide-inhibition studies Journal of General Virology ·Kristina Löhr, John E. Knox, Wai Yee Phong, Ngai Ling, Zheng Yin, Aruna Sampath, Sejal Patel, Weiling Wang, Wai-Ling Chan, K. R. Ranga Rao, Gang Wang, Subhash G. Vasudevan, Thomas H. Keller, Siew Pheng Lim	2007	30
9	Abstract 3595: RMC-6291, a next-generation tri-complex KRASG12C(ON) inhibitor, outperforms KRASG12C(OFF) inhibitors in preclinical models of KRASG12C cancers Cancer Research ·Robert J. Nichols, Yu Chi Yang, Jim Cregg, Chris J. Schulze, Zhican Wang, Richa Dua, Jingjing Jiang, Lindsay S. Garrenton, Nicole Nasholm, Alun Bermingham, John E. Knox, Kyle J. Seamon, Michael Longhi, Kang-Jye Chou, Shaoling Li, David Wildes, Mallika Singh, Elena S. Koltun, Adrian L. Gill, Jacqueline A.M. Smith	2022	28
10	Abstract 3596: RM-036, a first-in-class, orally-bioavailable, Tri-Complex covalent KRASG12D(ON) inhibitor, drives profound anti-tumor activity in KRASG12D mutant tumor models Cancer Research ·John E. Knox, Jingjing Jiang, G. Leslie Burnett, Yang Liu, Caroline E. Weller, Zhican Wang, Laura McDowell, Shelby L. Steele, Shook Chin, Kang Jye Chou, Fang Wang, Mengqi Zhong, Elena S. Koltun, David Wildes, Mallika Singh, Adrian L. Gill, Jacqueline A.M. Smith	2022	27
11	Weak Carbon−Hydrogen−Nitrogen Interactions Affect the Heterocyclic Ligand Bonding Modes in Barium Complexes Containing η²-Tetrazolato and η²-Pentazolato Ligands Inorganic Chemistry ·Issam Kobrsi, John E. Knox, Mary Jane Heeg, H. Bernhard Schlegel, Charles H. Winter	2005	26
12	Discovery of dual-activity small-molecule ligands of Pseudomonas aeruginosa LpxA and LpxD using SPR and X-ray crystallography Scientific Reports ·Kyle G. Kroeck, M. Sacco, Emmanuel W. Smith, Xiujun Zhang, Daniel Shoun, Afroza Akhtar, Sophie E. Darch, Frederick Cohen, Logan D. Andrews, John E. Knox, Yu Chen	2019	23
13	Experimental and Theoretical Study of the Coordination of 1,2,4-Triazolato, Tetrazolato, and Pentazolato Ligands to the [K(18-crown-6)]⁺ Fragment Inorganic Chemistry ·Issam Kobrsi, Wenjun Zheng, John E. Knox, Mary Jane Heeg, H. Bernhard Schlegel, Charles H. Winter	2006	23
14	Synthesis, Structure, and Molecular Orbital Calculations of (Pyrazolato)vanadium(III) Complexes − Understanding η2-Pyrazolato Ligand Coordination on d2 Metal Centers European Journal of Inorganic Chemistry ·K.R. Gust, John E. Knox, Mary Jane Heeg, H. Bernhard Schlegel, Charles H. Winter	2002	22
15	Abstract 3475: RMC-9805, a first-in-class, mutant-selective, covalent and orally bioavailable KRASG12D(ON) inhibitor, promotes cancer-associated neoantigen recognition and synergizes with immunotherapy in preclinical models Cancer Research ·Marie Ménard, Christopher W.K. Chow, Kevin Chen, Cristina Blaj, Nataliya Tovbis Shifrin, Haley Courtney, Nicole Nasholm, Anna Pham, Alice Kumamoto, Swetha Ganesh, James Evans, Lindsey Lawrence, Brian Vonmelchert, Amy C. Kwok-Parkhill, Jingjing Jiang, John E. Knox, Jacqueline A.M. Smith, Elsa Quintana	2023	18
16	Synthesis, Structure, and Properties of Magnesocene Amine Adducts. Structural Distortions Arising from N−H···C₅H₅^- Hydrogen Bonding and Molecular Orbital Calculations Thereof Organometallics ·Aibing Xia, John E. Knox, Mary Jane Heeg, H. Bernhard Schlegel, Charles H. Winter	2003	17
17	Extrusion of Teeth by Elastics: Report of Two Cases The Journal of the American Dental Association ·Bruno W. Kwapis, John E. Knox	1972	15
18	Synthesis, Structure, and Molecular Orbital Calculations of Chromium(III) and Iron(III) Complexes Containingη²-Pyrazolato Ligands Angewandte Chemie ·K.R. Gust, John E. Knox, Mary Jane Heeg, H. Bernhard Schlegel, Charles H. Winter	2002	14
19	Abstract ND03: Discovery of RMC-9805, an oral, covalent tri-complex KRASG12D(ON) inhibitor Cancer Research ·John E. Knox, G. Leslie Burnett, Caroline E. Weller, Lingyan Jiang, Dongyu Zhang, Nicole Vita, Abby Marquez, Kyle J. Seamon, Andrea Gould, Marie Ménard, Elsa Quintana, Zhe Chen, Zhican Wang, Zhengping Wang, Elena S. Koltun, Malika Singh, Jingjing Jiang, David Wildes, Jacqueline A.M. Smith, Adrian L. Gill	2024	12
20	Abstract 3598: A first-in-class tri-complex KRASG13C(ON) inhibitor validates therapeutic targeting of KRASG13Cand drives tumor regressions in preclinical models Cancer Research ·Christopher J. Schulze, Jim Cregg, Kyle J. Seamon, Yu Chi Yang, Zhican Wang, Lindsay S. Garrenton, Alun Bermingham, John E. Knox, Aidan C.A. Tomlinson, Kang-Jye Chou, Shaoling Li, David Wildes, Mallika Singh, Elena S. Koltun, Adrian L. Gill, Robert J. Nichols, Jacqueline A.M. Smith	2022	10

About John E. Knox

John E. Knox is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Infectious Diseases and Public Health, Environmental and Occupational Health, having authored 29 papers that have together received 806 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), Metal complexes synthesis and properties (6 papers), 14-3-3 protein interactions (4 papers), Organometallic Complex Synthesis and Catalysis (4 papers), Mosquito-borne diseases and control (4 papers), Magnetism in coordination complexes (4 papers), Signaling Pathways in Disease (3 papers) and Molecular Junctions and Nanostructures (3 papers). The work is most often cited by research in Virology (63 citations), Public Health, Environmental and Occupational Health (263 citations), Infectious Diseases (162 citations), Organic Chemistry (189 citations) and Molecular Medicine (28 citations). John E. Knox has collaborated with scholars based in United States, Singapore and Switzerland. Frequent co-authors include H. Bernhard Schlegel, Thomas H. Keller, Mary Jane Heeg, Charles H. Winter, Zheng Yin, Subhash G. Vasudevan, Siew Pheng Lim, Ngai Ling, Sejal Patel and David Beer. Their work appears in journals such as Cancer Research, Bioorganic & Medicinal Chemistry Letters, Inorganic Chemistry, European Journal of Inorganic Chemistry and Journal of Antimicrobial Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

John E. Knox

Impact in

Papers in i

In The Last Decade

John E. Knox

Peers

Countries citing papers authored by John E. Knox

Fields of papers citing papers by John E. Knox

All Works

About John E. Knox

Explore authors with similar magnitude of impact

Papers in